---
title: Pharmacovigilance & Drug Safety CROs in United Kingdom
path: /services/pharmacovigilance/united-kingdom
companies_count: 13
---

# Pharmacovigilance & Drug Safety CROs in United Kingdom

13 published CROs match Pharmacovigilance & Drug Safety in United Kingdom.

Locations in this set include United Kingdom, United States, Poland, Spain, Australia, and France.

Capabilities that show up most often in this set: Vaccine, Biologics (Other), Small Molecule, Cell Therapy, and Gene Therapy.

## Matching companies

- [Clarenta](/companies/comac-medical)
  - Clarenta (formerly Comac Medical Group) is a pan-European CRO offering full-service trial delivery and early-phase studies, including first-in-human and PK work. It runs a Phase I unit in Sofia and has depth in oncology and rare diseases.
- [ERGOMED Group](/companies/ergomed)
  - Global, full-service CRO specializing in oncology and rare disease clinical development, with complementary pharmacovigilance and QA consulting brands.
- [Emerald Clinical](/companies/emeraldclinical)
  - Global clinical research organization with 25+ years of expertise, headquartered in Singapore with operations across Asia-Pacific, EMEA, and the Americas. Specializes in renal, oncology, cardiovascular, and early-phase research with deep scientific leadership and proven operational excellence.
- [ICON plc](/companies/iconplc)
  - ICON is a global clinical research organization providing full-service drug development and clinical trial solutions across early phase through post-marketing, including clinical operations, bioanalytical labs, cardiac safety, medical imaging, and regulatory affairs.
- [Medpace](/companies/medpace)
  - Full-service CRO with 30+ years of organic growth, offering integrated clinical development services across all phases with wholly-owned central labs, bioanalytical lab, imaging core lab, and Phase I unit.
- [PPD](/companies/ppd)
  - PPD is a leading global contract research organization (CRO) and the clinical research business of Thermo Fisher Scientific.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [Premier Research](/companies/premier-research)
  - Premier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.
- [PrimeVigilance](/companies/primevigilance)
  - Pharmacovigilance and safety services provider offering end-to-end operations, technology-driven solutions, and specialized expertise in vaccines, CGT/ATMP, pediatric medicines, and geriatric populations.
- [Quanticate](/companies/quanticate)
  - Quanticate is a biometrics CRO with 30 years of expertise in biostatistics, clinical data management, and pharmacovigilance across all clinical trial phases. The company specializes in statistical protocol design, CDISC standards compliance, and real-world data analysis to support regulatory submissions.
- [Simbec-Orion](/companies/simbecorion)
  - Full-service CRO delivering clinical trial management across early to late phases, with specialist expertise in rare diseases and oncology.
- [Sofpromed](/companies/sofpromed)
  - Full-service CRO specializing in Phase I–IV clinical trials across oncology, cardiovascular, metabolic, CNS, dermatological, infectious, and respiratory diseases, with global trial management capabilities and expertise in rare tumor research.
- [TFS HealthScience](/companies/tfscro)
  - Global mid-size CRO specializing in dermatology, internal medicine, neuroscience, oncology, and ophthalmology with Phase I-IV clinical development, real-world evidence studies, and flexible resourcing solutions across 600+ experts in Europe, North America, and Australia.
